ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 586

$572K Total Retail Price of All Prescriptions

Rank: 11 out of 586

606 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,881 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 630 482 1 3
LISINOPRIL 443 362 2 4
LEVOTHYROXINE SODIUM 439 387 3 2
SIMVASTATIN 416 330 4 1
METFORMIN HCL 357 277 5 6
PRAVASTATIN SODIUM 320 258 6 22
HYDROCHLOROTHIAZIDE 315 259 7 10
FUROSEMIDE 232 200 8 9
AMLODIPINE BESYLATE 232 191 8 7
HYDROCODONE-ACETAMINOPHEN 211 166 S3 10 5
GABAPENTIN 209 178 11 11
METOPROLOL SUCCINATE 200 172 12 19
METOPROLOL TARTRATE 187 161 13 26
TAMSULOSIN HCL 186 166 14 27
FLUOXETINE HCL 161 129 15 24
WARFARIN SODIUM 141 136 16 13
CITALOPRAM HBR 140 114 17 12
RANITIDINE HCL 137 77 18 61
TRAMADOL HCL 126 110 19 15
ATENOLOL 119 112 20 34
TRAZODONE HCL 117 89 21 20
KLOR-CON M20 113 101 22 92
ZOLPIDEM TARTRATE 109 74 23 8
POTASSIUM CHLORIDE 108 88 24 14
ADVAIR DISKUS 104 82 25 59
LOSARTAN POTASSIUM 99 87 26 18
SERTRALINE HCL 98 84 27 21
AZITHROMYCIN 88 67 28 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 73 28 16
CARVEDILOL 77 58 30 30
MELOXICAM 76 55 31 25
ATORVASTATIN CALCIUM 74 61 32 17
FLUTICASONE PROPIONATE 73 57 33 28
DIOVAN 71 68 34 72
AMITRIPTYLINE HCL 71 66 R 34 62
CIPROFLOXACIN HCL 69 54 36 82
FINASTERIDE 67 54 37 84
LANTUS SOLOSTAR 67 61 37 80
LANTUS 66 54 39 33
PREDNISONE 65 57 40 56
ALENDRONATE SODIUM 62 62 41 23
LORAZEPAM 62 56 41 217
GLIPIZIDE 62 55 41 124
GLYBURIDE 61 54 R 44 101
LOVASTATIN 61 61 44 48
IBUPROFEN 60 42 46 43
NAMENDA 59 47 47 54
DONEPEZIL HCL 57 44 48 40
OXYBUTYNIN CHLORIDE 54 48 49 83
ESTRADIOL 52 29 R 50 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.